<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) September 23, 1997
------------------
AVITAR, INC.
-------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-20316 06-1174053
- ----------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
65 Dan Road, Canton, MA 02021
- -----------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (617) 821-2440
---------------
<PAGE>
Item 5. Other Events.
On September 23, 1997, the Registrant announced a Letter of Intent with
a national managed care company for the sale of substantially all of the
assets of the Registrant's Managed Health Benefits (MHB) subsidiary for $1.3
million. The sale is subject to the completion of due diligence by the
purchaser and approval by the boards of directors of both companies. The
proposed transaction is expected to close during the fourth quarter of 1997.
Item 7. Exhibits.
(c) Exhibits
(99) Press release issued September 23, 1997
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AVITAR, INC.
(Registrant)
Date: September 24, 1997 By: /s/J.C. LEATHERMAN
--------------------------
J.C. LEATHERMAN, JR.,
Chief Financial Officer
EXHIBIT (99) Press release issued September 23, 1997
FOR IMMEDIATE RELEASE
AVITAR, INC. TO SELL ITS MANAGED HEALTH BENEFITS UNIT
Canton, MA September 23, 1997 -- Avitar, Inc. (Nasdaq SmallCap Market:AVIT)
today announced a Letter of Intent with a national managed care company, for
the sale of substantially all of the assets of Avitar's Managed Health
Benefits (MHB) subsidiary for $1.3 million. The sale, which is subject to the
completion of due diligence and approval by the boards of directors of both
companies, is expected to close during the Fourth Quarter of 1997.
Peter P. Phildius, Chairman & CEO of Avitar, stated, "The sale of MHB will
allow the management of Avitar to focus on its core medical products business.
Avitar currently produces medical devices from a proprietary polyurethane foam
and, as recently announced, has developed a state-of-the-art saliva collection
system for saliva based diagnostic tests. The Company is currently conducting
clinical trials on its first saliva based drugs-of-abuse test. We intend to
expand our efforts to develop new products and further grow our existing
markets.
"With the rapidly changing managed care market, the long-term success of
Managed Health Benefit's highly specialized cost containment services will
best be served by it becoming part of a larger, more diverse managed care
company," Mr. Phildius concluded.
Avitar, Inc. primarily designs, develops, manufactures and markets healthcare
products, including a proprietary line of polyurethane wound care dressings
and rapid diagnostic test products.
"Safe Harbor" statement under the Private Securities Reform Act of 1995: This
release contains forward looking statements that are subject to risks and
uncertainties referred to above and as detailed from time to time in the
Company's filings with the Securities & Exchange Commission.
AVITAR, INC. CONTACT:
Peter Phildius, Chairman of the Board
(617) 575-9790
Jay Leatherman, Chief Financial Officer
(203) 265-3594
